Breast cancer, hereditary (gene panel)

Genetic test Export to PDF
Full name:
Breast cancer, hereditary (gene panel)
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Carrier diagnosis,
Drug Response,
Mutation confirmation,
Post-natal Diagnosis,
Pre-implantation genetic diagnosis,
Predictive and Pre-symptomatic diagnosis,
Prenatal diagnosis,
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA,
Amniotic fluid,
Chorionic villi,
Cell culture
Method category:
Method technique:
Laboratory:
RIZIV code:
EQA:
  • 2015 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2016 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2017 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2018 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2019 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2020 Hereditary Breast and Ovarian Cancer (panel testing) EMQN
  • 2021 Hereditary Breast and Ovarian Cancer (panel testing) EMQN
  • 2022 Hereditary Breast and Ovarian Cancer (panel testing) EMQN
Accreditation (ISO 15189):
2021-10-07 / 2026-06-14
Turnaround time (maximum):
3 months (10 working days for prenatal diagnosis)
Document(s):
Created:
23 Aug 2019 - 16:51
Changed:
01 Mar 2023 - 16:30
URL: